RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26817820.
- Also identified by DOI 10.1038/ncomms10548 and PMC identifier 4738357.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Zinc-finger nuclease, transcription activator-like effector nuclease and CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) are becoming major tools for genome editing. Importantly, knock-in in several non-rodent species has been finally achieved thanks to these customizable nucleases; yet the rates remain to be further improved. We hypothesize that inhibiting non-homologous end joining (NHEJ) or enhancing homology-directed repair (HDR) will improve the nuclease-mediated knock-in efficiency. Here we show that the in vitro application of an HDR enhancer, RS-1, increases the knock-in efficiency by two- to five-fold at different loci, whereas NHEJ inhibitor SCR7 has minimal effects. We then apply RS-1 for animal production and have achieved multifold improvement on the knock-in rates as well. Our work presents tools to nuclease-mediated knock-in animal production, and sheds light on improving gene-targeting efficiencies on pluripotent stem cells.
Medical subject headings
- Benzamides
- DNA End-Joining Repair
- Gene Knock-In Techniques
- Pyrimidines
- Recombinational DNA Repair
- Schiff Bases
- Sulfonamides